PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture
- PMID: 11241737
PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture
Abstract
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of the nuclear hormone receptor superfamily that have been described as master genes that switch cells from an undifferentiated phenotype to a differentiated phenotype. In the present investigation, we examined the possibility that ligands for PPARs are potent activators of oligodendrocyte (OL) differentiation and/or proliferation. Primary glial cultures and enriched OL cultures of neonatal mouse cerebra were treated with three different PPAR agonists: a PPAR gamma-selective agonist, a PPAR delta-selective agonist, and a pan agonist selective for both PPAR gamma and delta. Treatment with PPAR gamma agonist does not have an effect on the differentiation of OLs; however, PPAR delta agonist and the pan agonist treatment accelerates the differentiation of OLs within 24 h of application in mixed glial cultures. The number of OLs with processes and huge membrane sheets increases two- to threefold in both groups. The increase in the size of the sheets is also mirrored by changes in the intensity and distribution of myelin basic protein (MBP) and proteolipid protein (PLP) mRNAs. As compared to controls, the PPAR delta agonist-treated groups contain more OLs that have MBP and PLP mRNA extending into distal processes. These results indicate that PPAR delta plays a significant role in the maturation of OLs and regulates the size of OL sheets. BrdU immunostaining reveals that these agonists do not significantly stimulate proliferation of OLs expressing glycolipids. The studies in enriched OL cultures reproduce the effects of the PPAR agonists seen in the mixed glial cultures, indicating that the effect of the PPAR agonists is directly on the OLs and not via astrocytes. In the enriched cultures, the total number of OLs increases significantly in the PPAR delta agonist-treated groups, but BrdU immunostaining does not show an increased proliferation of cells. These findings suggest that PPAR delta increases the survival of cells and/or prevents cell death in enriched cultures. Although PPAR delta is expressed in various cell types, its role as a factor in the transcriptional regulation of OL differentiation has not been explored. We show for the first time that a ligand that serves as an agonist for PPAR delta activates the program of OL differentiation in primary and enriched OL cultures.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.Mol Genet Metab. 2001 Nov;74(3):362-9. doi: 10.1006/mgme.2001.3242. Mol Genet Metab. 2001. PMID: 11708867
-
PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes.J Neurosci Res. 2003 May 15;72(4):425-35. doi: 10.1002/jnr.10596. J Neurosci Res. 2003. PMID: 12704804
-
A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.J Cell Physiol. 2008 Nov;217(2):367-76. doi: 10.1002/jcp.21509. J Cell Physiol. 2008. PMID: 18543250
-
The nuclear receptor peroxisome proliferator-activated receptor-γ promotes oligodendrocyte differentiation through mechanisms involving mitochondria and oscillatory Ca2+ waves.Biol Chem. 2013 Dec;394(12):1607-14. doi: 10.1515/hsz-2013-0152. Biol Chem. 2013. PMID: 23770533 Review.
-
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.Lancet Oncol. 2004 Jul;5(7):419-29. doi: 10.1016/S1470-2045(04)01509-8. Lancet Oncol. 2004. PMID: 15231248 Review.
Cited by
-
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.J Biol Chem. 2012 Oct 5;287(41):34134-48. doi: 10.1074/jbc.M112.398552. Epub 2012 Aug 9. J Biol Chem. 2012. PMID: 22879602 Free PMC article. Clinical Trial.
-
Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord.J Comp Neurol. 2010 Mar 15;518(6):785-99. doi: 10.1002/cne.22242. J Comp Neurol. 2010. PMID: 20058304 Free PMC article.
-
Role of PPARs in Radiation-Induced Brain Injury.PPAR Res. 2010;2010:234975. doi: 10.1155/2010/234975. Epub 2009 Sep 17. PPAR Res. 2010. PMID: 19789638 Free PMC article.
-
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Drugs. 2017 Jan;77(1):47-65. doi: 10.1007/s40265-016-0674-0. Drugs. 2017. PMID: 27988872 Free PMC article. Review.
-
Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis.Int J Neuropsychopharmacol. 2015 Sep 10;19(1):pyv083. doi: 10.1093/ijnp/pyv083. Int J Neuropsychopharmacol. 2015. PMID: 26362775 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous